Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcellx (ACLX) Cash & Equivalents (2023 - 2025)

Arcellx (ACLX) has 3 years of Cash & Equivalents data on record, last reported at $80.3 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 24.05% year-over-year to $80.3 million; the TTM value through Dec 2025 reached $80.3 million, down 24.05%, while the annual FY2025 figure was $80.3 million, 24.05% down from the prior year.
  • Cash & Equivalents reached $80.3 million in Q4 2025 per ACLX's latest filing, up from $79.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $394.6 million in Q4 2023 and bottomed at $62.3 million in Q2 2025.
  • Average Cash & Equivalents over 3 years is $160.3 million, with a median of $115.9 million recorded in 2023.
  • The widest YoY moves for Cash & Equivalents: up 28.33% in 2024, down 73.22% in 2024.
  • A 3-year view of Cash & Equivalents shows it stood at $394.6 million in 2023, then tumbled by 73.22% to $105.7 million in 2024, then dropped by 24.05% to $80.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $80.3 million in Q4 2025, $79.0 million in Q3 2025, and $62.3 million in Q2 2025.